MicroRNA-148a is down-regulated in human pancreatic ductal adenocarcinomas and regulates cell survival by targeting CDC25B.
about
The Role of Mir-148a in CancerManaging Pancreatic Adenocarcinoma: A Special Focus in MicroRNA Gene TherapyNon-invasive biomarkers in pancreatic cancer diagnosis: what we need versus what we haveMicroRNA in pancreatic ductal adenocarcinoma and its precursor lesionsHIV-associated neuropathogenesis: a systems biology perspective for modeling and therapyNoncoding RNAs in DNA repair and genome integrityIdentification of novel and differentially expressed MicroRNAs of dairy goat mammary gland tissues using solexa sequencing and bioinformaticsmicroRNA-148a is a prognostic oncomiR that targets MIG6 and BIM to regulate EGFR and apoptosis in glioblastoma.Identfication of key miRNAs in pancreatitis using bioinformatics analysis of microarray dataMolecular Drivers of Pancreatic Cancer Pathogenesis: Looking Inward to Move Forward.Epigenetics and pancreatic cancer: pathophysiology and novel treatment aspectsTargeting miRNAs for pancreatic cancer therapyMicroRNA alterations of pancreatic intraepithelial neoplasiasSilencing of miRNA-148a by hypermethylation activates the integrin-mediated signaling pathway in nasopharyngeal carcinomaThe clinical significance of MiR-148a as a predictive biomarker in patients with advanced colorectal cancer.The rescue of miR-148a expression in pancreatic cancer: an inappropriate therapeutic toolA systematic review of microRNA expression profiling studies in human gastric cancer.MicroRNA-148a is downregulated in gastric cancer, targets MMP7, and indicates tumor invasiveness and poor prognosis.microRNA-34a is associated with expression of key hepatic transcription factors and cytochromes P450Inhibition of CDC25B phosphatase through disruption of protein-protein interactionmiR-186 and 326 predict the prognosis of pancreatic ductal adenocarcinoma and affect the proliferation and migration of cancer cellsClinical implications of miRNAs in the pathogenesis, diagnosis and therapy of pancreatic cancer.MicroRNA-148a reduces tumorigenesis and increases TRAIL-induced apoptosis in NSCLCThe role of airway epithelial cells in response to mycobacteria infection.Targeting pancreatitis blocks tumor-initiating stem cells and pancreatic cancer progressionHepatitis B virus X protein represses miRNA-148a to enhance tumorigenesis.MicroRNA-141 is downregulated in human renal cell carcinoma and regulates cell survival by targeting CDC25B.The microRNA-148/152 family: multi-faceted playersMiR-148a functions to suppress metastasis and serves as a prognostic indicator in triple-negative breast cancer.DNMT1 is regulated by ATP-citrate lyase and maintains methylation patterns during adipocyte differentiation.miR-592/WSB1/HIF-1α axis inhibits glycolytic metabolism to decrease hepatocellular carcinoma growth.Increased expression of microRNA-148a in osteosarcoma promotes cancer cell growth by targeting PTEN.Drug resistance-related microRNAs in esophageal cancer.Developments in miRNA gene signaling pathways in pancreatic cancer.New developments in the early diagnosis of pancreatic cancer.Translating microRNAs into biomarkers: What is new for pediatric cancer?MicroRNA-148a inhibits migration of breast cancer cells by targeting MMP-13.MicroRNA in pancreatic cancer.MicroRNA-211, a direct negative regulator of CDC25B expression, inhibits triple-negative breast cancer cells' growth and migration.MicroRNA-148a suppresses epithelial-to-mesenchymal transition by targeting ROCK1 in non-small cell lung cancer cells.
P2860
Q26743549-F8B906DA-1D08-4935-8EC6-0CAF93EEE296Q26749037-C297F418-E2FC-4014-BF36-B8DC88A21FE2Q26750944-DA370C01-46EF-4E24-B533-C7D735960E8CQ26769953-553F811B-3108-45ED-8B6D-4C894FD5E8E1Q26859071-461C8BA1-FE3C-489C-B6FA-1E16BF4FE35AQ26864697-51E29703-AD0C-4ADF-985A-97CB22433535Q27335907-4296629B-4239-4388-A91B-9FD10AD934BDQ30407637-2B3391A4-B56B-4BFA-A1D2-602FAF982537Q31142190-85E1C76A-55ED-4867-A2A6-ACF2680C2CE4Q33624574-F1CF8890-A08B-4DED-8FDC-B7FB0F8F0053Q33801377-4BA3C357-C77B-43B1-84B1-E5DF24A74E01Q33962488-0E200B0A-F82C-4FB7-A36D-AFA5A199C686Q34082610-32800C0B-6D8A-41DD-8455-DD5C15F05E10Q34365798-D13922A3-D857-4F17-A773-CBC99DB570EEQ34441849-6087FF00-2362-4A89-BC7A-8C94F1E023CEQ34576658-5EC0960F-1560-4DD5-A6FC-FF0BF54C94C5Q35000434-0339C587-AD1F-445B-B8C3-484A99F36DC3Q35051475-F2F85FD2-F555-4648-B5C8-669E1F743CF5Q35063942-6BFFD88F-7AD1-4B0A-BF79-B0BD7A691372Q35121087-E2123635-9B0F-48CE-8B61-639824BEAB35Q35151728-0F163C6C-4DDA-4A1D-AD35-DDF36D1A925EQ35735278-F01A43F8-58F8-4A72-887D-D126AA044761Q35865575-AAC1850D-5363-4229-AF33-707BEDABACA7Q35915391-2AB65FDA-E9DC-4F56-9CB8-AD056E8F4A04Q36021066-6C01BAF4-17BA-44FE-8DC3-99DF45E6A2D7Q36580378-A3D22982-AA33-4676-9BAE-D7D9CA40E7A4Q36768660-2CA48EDF-DC40-4717-86FA-8F90AA26B705Q36898251-17E9F034-961A-4994-AEAD-467C18FD9067Q37190321-D0BA0ACE-BED1-4AB4-9EE7-53AB262C3E33Q37264962-C3BB9936-9811-4C9F-B543-0FE0753B649AQ37376524-FF462B5C-834E-4387-B164-B542F2662EB5Q37406865-E32F7E12-C94E-43D2-883C-14ABBBACBD60Q38029108-7ADCEB99-88B0-49C1-911E-FB18CE79F9EEQ38777530-52FDA3A2-011E-4A15-BC49-C50B44ECBA2CQ38784810-72382E3D-43B8-4D3E-9EF2-6501EE75B82AQ38810073-AF6CCA36-A5FD-4AD6-900E-B67C9983A8A8Q38841626-BEEDC84F-FF37-4DCC-BC3F-0C768FE39542Q38850617-62C7E15A-C091-4203-8B08-86A05E658E2BQ38909934-9C00193D-5A20-40C0-BD35-088DFDA26CE6Q39152457-BCDB87A8-460F-4D6B-966A-DF88ECC1EACE
P2860
MicroRNA-148a is down-regulated in human pancreatic ductal adenocarcinomas and regulates cell survival by targeting CDC25B.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
MicroRNA-148a is down-regulate ...... survival by targeting CDC25B.
@en
type
label
MicroRNA-148a is down-regulate ...... survival by targeting CDC25B.
@en
prefLabel
MicroRNA-148a is down-regulate ...... survival by targeting CDC25B.
@en
P2093
P2860
P1476
MicroRNA-148a is down-regulate ...... survival by targeting CDC25B.
@en
P2093
Abdelouahid Maghnouj
Alireza Mirmohammadsadegh
Andrea Tannapfel
Berlinda Verdoodt
Jan D Kuhlmann
Johanna B Munding
Markus Vogt
Sandeep Nambiar
Stephan A Hahn
Sven-T Liffers
P2860
P2888
P304
P356
10.1038/LABINVEST.2011.99
P577
2011-06-27T00:00:00Z
P5875
P6179
1019679385